BRIEF-Black Diamond Therapeutics Announces Restructuring Plan To Focus Resources On Bdtx-1535 And Extend Cash Runway

Reuters

Oct 08, 2024

Black Diamond Therapeutics Inc :

* BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO FOCUS RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY

* BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE BDTX-4933 AND SEEK POTENTIAL PARTNERS

* BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2026

* BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO FUND OPERATIONS INTO Q2 2026

* BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY SEEKING PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN RAF/RAS-MUTANT SOLID TUMORS

* BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO ELIZABETH MONTGOMERY DEPARTING BLACK DIAMOND

* BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT IN BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A REDUCTION IN FORCE

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2473352824"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2473352824\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2473352824?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-08 04:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2473352824","market":"us","top_or_hot":-1,"title":"BRIEF-Black Diamond Therapeutics Announces Restructuring Plan To Focus Resources On Bdtx-1535 And Extend Cash Runway","media":"Reuters","content":"<html><body><p>Black Diamond <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO FOCUS RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY</p><p>   * BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE BDTX-4933 AND SEEK POTENTIAL PARTNERS</p><p>   * BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2026</p><p>   * BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO FUND OPERATIONS INTO Q2 2026</p><p>   * BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY SEEKING PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN RAF/RAS-MUTANT SOLID TUMORS</p><p>   * BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO ELIZABETH MONTGOMERY DEPARTING BLACK DIAMOND</p><p>   * BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT IN BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A REDUCTION IN FORCE</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Black Diamond Therapeutics Announces Restructuring Plan To Focus Resources On Bdtx-1535 And Extend Cash Runway</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Black Diamond Therapeutics Announces Restructuring Plan To Focus Resources On Bdtx-1535 And Extend Cash Runway\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-10-08 04:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Black Diamond <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO FOCUS RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY</p><p>   * BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE BDTX-4933 AND SEEK POTENTIAL PARTNERS</p><p>   * BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2026</p><p>   * BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO FUND OPERATIONS INTO Q2 2026</p><p>   * BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY SEEKING PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN RAF/RAS-MUTANT SOLID TUMORS</p><p>   * BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO ELIZABETH MONTGOMERY DEPARTING BLACK DIAMOND</p><p>   * BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT IN BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A REDUCTION IN FORCE</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2473352824","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473352824","pubTimestamp":1728332817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Black Diamond Therapeutics Inc   :   * BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO FOCUS RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY   * BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE BDTX-4933 AND SEEK POTENTIAL PARTNERS   * BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2026   * BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO FUND OPERATIONS INTO Q2 2026   * BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY SEEKING PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN RAF/RAS-MUTANT SOLID TUMORS   * BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO ELIZABETH MONTGOMERY DEPARTING BLACK DIAMOND   * BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT IN BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A REDUCTION IN FORCESource text for Eikon:    Further company coverage:","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BDE":"黑钻","BK4139":"生物科技","BDTX":"Black Diamond Therapeutics, Inc."},"translate_title":"简报-Black Diamond Therapeutics宣布重组计划，将资源集中在Bdtx-1535上并延长现金跑道","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDE":1,"LENZ":1,"BDTX":1},"content_text":"Black Diamond Therapeutics Inc   :   * BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO FOCUS RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY   * BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE BDTX-4933 AND SEEK POTENTIAL PARTNERS   * BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2026   * BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO FUND OPERATIONS INTO Q2 2026   * BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY SEEKING PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN RAF/RAS-MUTANT SOLID TUMORS   * BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO ELIZABETH MONTGOMERY DEPARTING BLACK DIAMOND   * BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT IN BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A REDUCTION IN FORCESource text for Eikon:    Further company coverage:","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}